Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthokine versus hyaluronic acid for pain control in knee osteoarthritis
IRCT20131124015515N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of autologous conditioned serum and sodium hyaluronate in knee osteoarthritis (OA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Total KOOS score and Total WOMAC score. Started Jan 2019; status: completed.
02
Drugs
autologous conditioned serumsodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20131124015515N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131124015515N6.